Xovoltib Afatinib 40 mg Tablet is used for treatment of non-small cell lung carcinoma. It has been formulated using afatinib dimaleate as main chemical with molecular formula C32H33ClFN5O11 and molecular mass of 718.088 g/mol. This tablet works by irreversibly inhibiting human epidermal growth factor receptor 2 and EGFR kinases. Xovoltib Afatinib 40 mg Tablet is known to have protein binding ability of 95% and gets mainly eliminated in feces.
Features:
Belongs to protein kinase inhibitor drug class
Blocks formation of new blood vessels by tumor cells
Has elimination half life of around 37 hours
Xovoltib Tablet
Product Details:
Brand | Xovoltib 40mg |
Category | Lung Cancer, Blood Cancer |
Certification | FDA, GMP |
Dosage Form | Oral |
Dose | 40 mg |
Dose Strength (Mg) | 40 mg |
Dose/Strength | Afatinib 40mg |
Drug | Anti Cancer drug |
Form | Tablets |
Form of Medicine | Tablets |
Manufactured By | B.I. |
No of tablets | 28 |
Other Name | Afatinib Tablets |
Pack | 1*28 tablets |
Packaging Size | 7 tablets/strip |
Packaging Type | Box |
Packing | 1*28 |
Quantity Per Pack | 1*28 tablets |
Storage | Room Temperature |
Type | Allopathic |
Usage | Commercial, Clinical, Hospital, Personal |
Afatinib Tablets 80 mg
Additional Information:
SURETY HEALTHCARE
All Rights Reserved.(Terms of Use) Developed and Managed by Infocom Network Private Limited. |